Drugmakers Are Increasing U.S. Prices In 2018


Drugmakers have already increased the prices on dozens of medicines for 2018. Early data shows that the increases are generally within a 10% self-imposed limit in response to backlash from politicians and consumers. Allergan Inc increased prices on 18 different drugs, including the popular dry eye treatment Restasis and irritable bowel syndrome drug Linzess. Other companies raising prices include Amgen Inc., Teva Pharmaceutical Industries and Horizon Pharma.